Waveup’s Post

Check out our latest investor chat with Krish W. Ramadurai, Partner at Harmonix ! Harmonix is a venture capital firm focused on investing in breakthrough technologies at the intersection of life sciences, healthcare, and deep technology. With a strong commitment to ethics, social impact, and scientific advancements, Harmonix aims to support and empower entrepreneurs to develop and scale their groundbreaking ideas, creating a comprehensive ecosystem for innovation and growth. For more information about Harmonix, its investment approach, and portfolio companies, please visit https://harmonixfund.com/. Some key highlights from our conversation include: 💡 Harmonix has invested in over 40 companies with $7B in enterprise value across them 💡 They invest across the spectrum of early stage companies from seed to series B 💡 When seeking VC funding, always start off with a "get to know" instead of "an ask" 💡 Founders need to develop a "must have" not a "nice to have". When pitching VCs, you need to connect the dots to show that customers want your product tomorrow and why it's imperative you have capital today Thank you Krish for taking the time to speak with us! #venturecapital #lifescience #vc #healthcare #invest #startups

Venture Capital: The Catalyst for HealthTech Advancements Venture capital plays a crucial role in the HealthTech boom by providing essential funding, strategic guidance, and valuable networks. Learn how VCs are supporting startups to bring groundbreaking health solutions to market, driving significant advancements in patient care and efficiency. #VentureCapital #HealthTech #InvestmentStrategies 

Whole class of companies that should never raise an ounce of venture capital. #digitalhealth - BeKey Summary: In the blog post "Whole class of companies that should never raise an ounce of venture capital," the speaker discusses the implications of venture capital funding in the digital health sector. The key points covered in the blog post include: #VentureCapital in Digital Health: The speaker highlights the challenges faced by digital health companies when it comes to raising venture capital. They argue that not all companies in the digital health sector should seek VC funding. #Bootstrapping Success Stories: The blog post features success stories of digital health companies that have thrived without venture capital funding. These companies have achieved growth and sustainability through bootstrapping. #Sustainable Growth Strategies: The speaker emphasizes the importance of sustainable growth strategies for digital health companies. They discuss alternative funding ai.mediformatica.com #ankitjain #digital #digitalhealth #health #interview #profitability #seriesa #venturecapital #youtube #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4dznfcW)

In the high-stakes world of healthcare venture capital, it’s the collective strengths and qualities of a startup team that are just as vital as the innovations they pioneer. Success in healthcare is more than just a brilliant spark of an idea – it's the harmonious blend of know-how, seasoned insight, and unwavering determination. This combination propels a startup through a sector known for rigorous regulations, extended product development journeys, and complex payment systems. It's the team's deep-rooted expertise and their collective push against the tide that form the cornerstone of a thriving healthcare venture. Here's why healthcare VCs scrutinize the team behind the startup: -Expertise and Experience: The healthcare sector demands a nuanced understanding of clinical workflows, patient needs, and the larger healthcare ecosystem. A team that combines entrepreneurial spirit with deep healthcare domain experience stands a better chance at crafting solutions that resonate with healthcare providers, payers, and patients alike. -Compliance and Regulation: Healthcare startups must navigate a labyrinth of regulations, from HIPAA compliance to FDA approvals. A team well-versed in these areas can significantly de-risk the venture by ensuring that products not only meet regulatory standards but are designed with compliance in mind from the outset. -Execution and Traction: Ideas are plentiful, but execution is key. A team with a track record of bringing products to market can signal to investors the ability to execute the startup's vision, drive adoption, and achieve meaningful traction in a competitive space. -Resilience and Adaptability: Healthcare is an ever-evolving field. Teams that demonstrate the resilience to overcome scientific setbacks, and the adaptability to pivot in response to market feedback or regulatory changes, are a more attractive bet for investors looking for long-term players. In essence, when healthcare VCs invest, they're not just investing in a product, they're investing in a group of people poised to make a significant impact on the industry. The right team can turn trials into triumphs, and this is the beacon that guides savvy investors in their quest to back the next big breakthrough in healthcare. #venturecapital #healthcare #healthcareinnovation #vc #venturecapitalist #startupfunding #businessfunding #team #startup

⁉️Let's flip the script for a moment: We’ve explored how venture capital (#VC) fuels innovation and growth in healthcare and delved into expert insights on Portfolio Management and #Investment Thesis Design. ⤵️ What if we consider the reverse pitch concept? This approach provides a unique perspective on what venture capitalists seek in healthcare #startups and emerging #technologies. Understanding this can offer invaluable insights and boost your know-how early in your entrepreneurial journey. Ken Nelson, Partner at ADVANTAGE MEDTECH LIMITED, lead the conversation with Sanchita Pasi | Bhavesh Barot, Operating Partner & CBO, Truffle Capital | Amir Soltanianzadeh, Founder & Managing Partner, Solardis Health Ventures | Enric Claverol , PhD, Head of the Medical Technologies Programme, European Commission | Julien L. Pham, MD, MPH, Founder & Managing Partner, 3CC | Third Culture Capital | Linus Rieder, Principal, 415 Capital | GREG MADDEN, Managing Partner, SV Health Investors. 📌 Check out their input: https://lnkd.in/d4vsBdpZ

Corporate Seed Funds – Nurturing the Next Big Disruption 💡 What if the next game-changing innovation in healthcare, energy, or technology didn’t emerge from a small startup, but from the strategic foresight of a corporate giant? Corporate seed funds make this possible. By investing in early-stage startups, corporations are no longer simply responding to industry disruptions—they are actively creating them. These seed funds provide early visibility into emerging technologies and trends that have the potential to reshape industries. This isn’t just about financial returns—it’s about securing a front-row seat in the innovation ecosystem. By engaging with startups at their inception, corporations can influence the trajectory of breakthrough technologies, ensuring that they align with their long-term strategic goals. The corporate seed fund model allows companies to act as both investor and innovator, cultivating the future of their industries from the ground up. This proactive role positions corporations as leaders in the innovation landscape, not just as participants. 🌍 Is your corporation actively engaging with early-stage innovation? Are you positioned to drive industry disruption rather than react to it? #CorporateSeedFund #InnovationLeadership #DisruptiveInnovation #StrategicInvestment #FutureOfBusiness

Do you have a great idea for a healthtech startup? Are you curious how they get funded? I just published a basic nuts and bolts blog about it on Medium. How Do Healthcare Startups Get Investment Funding? #healthtech #healthcarestartup #getfunded #seedfunding

In venture capital, the question of whether specialization is a driver of success has been a topic of discussion for many years. In healthtech, the evidence is clear: specialization makes a decisive difference. PitchBook’s latest report shines a spotlight on this: 📈 "Healthtech and pharma companies backed by firms with deep expertise were far more likely to record a successful IPO or acquisition than their generalist peers—with exit success rates of 75.5% in healthtech and 82.6% in pharma." Interestingly, the same is not true across sectors. Many other verticals, including fintech, don’t show a correlation between investor specialization and exits. 💼 "LPs looking to get the best of both worlds could adopt a version of the core-satellite portfolio construction approach. Under this framework, the core of their VC allocation would go to generalist investors in broad sectors, with satellite funds focused on verticals where they believe expertise will make a difference." #healthtech #venturecapital #specialists vs #generalists by PitchBook Nina Capital #wearenina

Medtech venture capital investment showed a strong recovery in the first quarter, indicating a positive trend that is expected to continue. Despite potential challenges such as fluctuating interest rates, increased regulatory scrutiny, and the upcoming presidential election, analysts from Pitchbook remain cautiously optimistic about the sector's growth. The latest report from Pitchbook reveals that medtech venture capital reached its highest level since late 2022, even though the number of deals remained low. This resilience in funding showcases a promising outlook for the industry. #MedtechInvesting #VentureCapital

#Investors & Venture Capital #Funds: Looking for promising hashtag #HealthTech startups to #invest in? 💡 Discover innovative HealthTech hidden #champions on R2GConnect.com! 51% of HealthTech companies on the platform are actively seeking investors to scale their solutions. With the new #InvestorCall service, you can connect with thousands of companies worldwide and explore technologies you might not find elsewhere. Publish your Investor Call for free until the end of 2024 and simplify your search for the next HealthTech leader. Learn more: https://bit.ly/3ZX9tOn #InvestorCall #InvestorService #Funding